Indeed, the HIF-2α-driven pexophagy and PPARα antagonism [125,127] changed the lipid profile in mice to a NAFLD-like pattern [128]. This evidence concerns the gene EPAS1 and metabolic dysfunction-associated steatotic liver disease.